Characterization of the immune response elicited by the vaccinia virus L3 protein delivered as naked DNA. Issue 15 (5th April 2018)

• Record Type: Journal Article
• Authors: Ramírez, Maite; Santos, Saritza; Martínez, Osmarie; Rodríguez, Ricardo; Miranda, Eric; Ramos-Perez, Willy D.; Otero, Miguel
• Is Part Of: Vaccine. Volume 36:Issue 15(2018)
• Page Start: 2049
• Page End: 2055
• Publication Date: 2018-04-05
• Subjects: L3L -- Vaccine -- Smallpox -- DNA-vaccine -- Novel antigen -- Bioterror agents; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2018.02.033
• Languages: English
• ISSNs: 0264-410X

Abstract

Highlights: Administration of pL3L as naked DNA promotes strong antigen-specific type II IFN response. CD8+ T cells are a major contributor to IFN-γ production in mice receiving pL3L. Our formulation does not promote antigen-specific IL-4 secretion. Animals immunized with pL3L have significantly higher IgG levels compared to control groups. Opsonizing (IgG2a) is the predominant isotype in experimental groups. Abstract: Poxviruses are complex dsDNA viruses with over 200 genes, many of them with unknown role in the stimulation of immune responses. Among these, the vaccinia virus (VACV) L3L ORF encodes an essential protein for the transcription of the VACV early genes. To the best of our knowledge, the immune response elicited by L3 has not been characterized. In this regard, our data describes a DNA L3-coding plasmid (pL3L) that stimulates both, humoral- and cell-mediated immune responses in a mouse model. Cell-mediated immune responses were measured by IFN-γ and IL-4 ELISPOT assays. We performed CD8 + cells depletion and flow cytometry analysis to account for the contribution of cytotoxic T lymphocytes in the IFN-γ production. Moreover, results from ELISPOT were confirmed by measuring the concentration of IL-4 and IFN-γ in supernatant of antigen-stimulated splenocytes by cytokine ELISA. Additionally, dominant antigenic regions of L3 protein were identified by epitope mapping analysis. Humoral immune responses were assessed by ELISA. Specifically, the production of total IgG, IgG1 (TH-2) and IgG2a (TH-1) were determined one week after the final immunization. Our ELISPOT data shows pL3L-immunized animals to produce significantly higher frequencies of IFN-γ Spot-Forming Cells (SFC) versus controls. IL-4 levels remained unchanged in all three groups, demonstrating the increase in antigen-specific IFN-γ releasing cells. Flow cytometry assay results showed that CD8 + T cells are a major contributor to the production of IFN-γ. Moreover, our formulation enhances the production of total IgG, predominantly IgG2a isotype. Immunization with pL3L promotes a robust cytotoxic immune response, crucial against viral pathogens. In addition, our vaccine candidate promotes an increase in IgG levels, especially IgG2a (TH-1 type). Our data encourages further studies of L3 as a novel antigen in vaccine development against poxviruses.